__NUXT_JSONP__("/drugs/Giredestrant", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1953133-47-5",chebiId:b,chemicalFormula:b,definition:"An orally available selective estrogen receptor degrader\u002Fdownregulator (SERD), with potential antineoplastic activity. Upon oral administration, giredestrant specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells.",fdaUniiCode:"28P3DU6DB3",identifier:"C147030",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C2116"],synonyms:["GDC 9545","GDC-49545","GIREDESTRANT",a,"RG6171","SERD GDC-9545","Selective Estrogen Receptor Degrader GDC-9545","Selective Estrogen Receptor Downregulator GDC-9545"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FGiredestrant",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Giredestrant","","2021-10-30T13:32:50.463Z")));